Mechanisms of enhancement of TRAIL tumoricidal activity against human cancer cells of different origin by dipyridamole. [electronic resource]
Producer: 20080624Description: 3435-45 p. digitalISSN:- 1476-5594
- Apoptosis -- drug effects
- Blotting, Northern
- Bone Neoplasms -- drug therapy
- Colonic Neoplasms -- drug therapy
- Cyclic AMP-Dependent Protein Kinases -- genetics
- Cyclic GMP-Dependent Protein Kinases -- genetics
- Dipyridamole -- pharmacology
- G1 Phase -- drug effects
- Humans
- Immunoblotting
- Inhibitor of Apoptosis Proteins
- Luciferases -- metabolism
- Male
- Microtubule-Associated Proteins -- antagonists & inhibitors
- Mutation -- genetics
- Neoplasm Proteins -- antagonists & inhibitors
- Neoplasms -- drug therapy
- Osteosarcoma -- drug therapy
- Phosphodiesterase Inhibitors -- pharmacology
- Prostatic Neoplasms -- drug therapy
- RNA, Small Interfering -- pharmacology
- Receptors, TNF-Related Apoptosis-Inducing Ligand -- antagonists & inhibitors
- Receptors, Tumor Necrosis Factor -- antagonists & inhibitors
- Survivin
- TNF-Related Apoptosis-Inducing Ligand -- metabolism
- Transcription Factor CHOP -- genetics
- Tumor Cells, Cultured
- Tumor Necrosis Factor-alpha -- pharmacology
- Tumor Suppressor Protein p53 -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.